ERDHEIM-CHESTER DISEASE

Clinical trials for ERDHEIM-CHESTER DISEASE explained in plain language.

Never miss a new study

Get alerted when new ERDHEIM-CHESTER DISEASE trials appear

Sign up with your email to follow new studies for ERDHEIM-CHESTER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1

UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers

Disease control Not yet recruiting

This trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…

Matched conditions: ERDHEIM-CHESTER DISEASE

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ERDHEIM-CHESTER DISEASE

Get alerted when new ERDHEIM-CHESTER DISEASE trials appear

UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers